Citations

Showing 10 of 108104 citations.

Echocardiographic Evaluation of Aorta to Right Atrial Fistula Secondary to Ruptured Sinus of Valsalva Aneurysm
Fritz, Ashley Virginia , Boles, Kathryn S., Fritz, Ashley V, Martin, Archer Kilbourne , Boles, Kathryn S.

Mayo Clinic

Annals of Cardiac Anaesthesia | July 25, 2018 | Volume: 21 | Issue: 3 | Pages: 313-314

10.4103/aca.aca_229_17 | PMID 30052225 Get It

We present the case of a 37 year old male who presented with new onset dyspnea, tachycardia, palpitations, and chest tightness. His initial work up demonstrated a dilated pulmonary artery with reflux of contrast dye in to the IVC. Transthoracic echocardiogram identified a “windsock” appearance indicating Sinus of Valsalva aneurysm (SVA) and severe aortic regurgitation. As a result, the patient was taken for emergent surgery where the windsock tissue was surgically repaired with bovine pericardial patch. This case illuminates the uncommon occurrence of SVA and the ability to recognize these findings on multiple imaging modalities including transthoracic, transesophageal two and three dimensional echocardiography as well as direct surgical field visualization.
The Development of an Effective Bacterial Single-Cell Lysis Method Suitable for Whole Genome Amplification in Microfluidic Platforms
Liu, Yuguang , Cockell, Charles S. , Leya, Thomas , Baqué, Mickaël , Walther-António, Marina , Leya, Thomas , Walther-Antonio, Marina , Schulze‐Makuch, Dirk , Vera, Jean-Pierre Paul De

Mayo Clinic

Micromachines | July 25, 2018 | Volume: 9 | Issue: 8 | Pages: 367

10.3390/mi9080367 | PMID 30424300 Get It

Single-cell sequencing is a powerful technology that provides the capability of analyzing a single cell within a population. This technology is mostly coupled with microfluidic systems for controlled cell manipulation and precise fluid handling to shed light on the genomes of a wide range of cells. So far, single-cell sequencing has been focused mostly on human cells due to the ease of lysing the cells for genome amplification. The major challenges that bacterial species pose to genome amplification from single cells include the rigid bacterial cell walls and the need for an effective lysis protocol compatible with microfluidic platforms. In this work, we present a lysis protocol that can be used to extract genomic DNA from both gram-positive and gram-negative species without interfering with the amplification chemistry. Corynebacterium glutamicum was chosen as a typical gram-positive model and Nostoc sp. as a gram-negative model due to major challenges reported in previous studies. Our protocol is based on thermal and chemical lysis. We consider 80% of single-cell replicates that lead to >5 ng DNA after amplification as successful attempts. The protocol was directly applied to Gloeocapsa sp. and the single cells of the eukaryotic Sphaerocystis sp. and achieved a 100% success rate.
Reply: Gender-Confirmation Surgery Using the Pedicle Transverse Colon Flap for Vaginal Reconstruction: A Clinical Outcome and Sexual Function Evaluation Study
Manrique, Oscar J. , Sabbagh, M. Diya , Ciudad, Pedro , Adabi, Kian , Huang, Tony Chieh‐Ting , Chen, Hung‐Chi

Mayo Clinic

Plastic & Reconstructive Surgery | July 25, 2018 | Volume: 142 | Issue: 4 | Pages: 606e-608e

10.1097/prs.0000000000004754 | PMID 30045162 Get It

Exercise Stroke Volume in Adult Cystic Fibrosis: A Comparison of Acetylene Pulmonary Uptake and Oxygen Pulse
Iterson, Erik H. Van , Baker, Sarah E. , Wheatley, Courtney M. , Olson, Thomas P. , Snyder, Eric M., Van Iterson, Erik H , Baker, Sarah E , Morgan, Wayne J.

Mayo Clinic

Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine | July 25, 2018 | Volume: 12 | Issue: No issue available | Pages: No page available

10.1177/1179548418790564 | PMID 30083061 Get It

Cardiac hemodynamic assessment during cardiopulmonary exercise testing (CPET) is proposed to play an important role in the clinical evaluation of individuals with cystic fibrosis (CF). Cardiac catheterization is not practical for routine clinical CPET. Use of oxygen pulse (O 2 pulse) as a noninvasive estimate of stroke volume (SV) has not been validated in CF. This study tested the hypothesis that peak exercise O 2 pulse is a valid estimate of SV in CF. Measurements of SV via the acetylene rebreathe technique were acquired at baseline and peak exercise in 17 mild-to-moderate severity adult CF and 25 age-matched healthy adults. We calculated [Formula: see text]. Baseline relationships between SV and O 2 pulse were significant in CF ( r = .80) and controls ( r = .40), persisting to peak exercise in CF ( r = .63) and controls ( r = .73). The standard error of estimate for O 2 pulse-predicted SV with respect to measured SV was similar at baseline (14.1 vs 20.1 mL) and peak exercise (18.2 vs 13.9 mL) for CF and controls, respectively. These data suggest that peak exercise O 2 pulse is a valid estimate of SV in CF. The ability to noninvasively estimate SV via O 2 pulse during routine clinical CPET can be used to improve test interpretation and advance our understanding of the impact cardiac dysfunction has on exercise intolerance in CF.
MULTIMODAL IMAGING OF CHOROIDAL AND OPTIC DISK VESSELS NEAR OPTIC DISK PITS
Adams, Matthew K., Cohen, Salomon Y. , Souied, Eric H., Goldenberg, Dafna, Olsen, Timothy W. , Pulido, José S. , Souied, Eric H. , Loewenstein, Anat

Mayo Clinic

RETINAL Cases & Brief Reports | July 25, 2018 | Volume: 14 | Issue: 4 | Pages: 289-296

10.1097/icb.0000000000000765 | PMID 30045152 Get It

Purpose: To describe modern multimodal imaging of the choroidal and optic disk vessels in optic disk pits. Methods: Case reports of four patients with optic disk pit who underwent multimodal imaging of the optic pit and surrounding structures. Patients included in this article were found to have optic disk pits and subsequently underwent multimodal imaging. Results: Cilioretinal arteries were present in two of the four cases (50%). SPECTRALIS optical coherence tomography showed intraretinal and subretinal fluid in all cases. Small vessels in the choroid and in the disk around the pit were also present in all cases through optical coherence tomographic angiography. Confocal fluorescein angiographic imaging in the first case showed leakage from the vessels adjacent to the optic disk pit. Conclusion: Modern multimodal imaging shows that there are anomalous vessels in and around an optic pit. Whether these vessels affect the development of optic pit, maculopathy needs to be further evaluated.
Autoimmune and Allergic Disorders are More Common in People With Celiac Disease or on a Gluten-free Diet in the United States
Ünalp–Arida, Aynur , Ruhl, Constance E. , Choung, Rok Seon , Kim, Hyun‐Seok , Murray, Joseph A. , Choung, Rok Seon

Mayo Clinic

Journal of Clinical Gastroenterology | July 25, 2018 | Volume: 53 | Issue: 10 | Pages: e416-e423

10.1097/mcg.0000000000001100 | PMID 30045167 Get It

Goals: We analyzed demographics, lifestyle patterns, and clinical characteristics of people with celiac disease (CD) and people without CD avoiding gluten (PWAG) to better understand associations with medical conditions and consumer behavior. Background: Clinical significance of CD and gluten avoidance in the general population is incompletely understood. Recently, a high incidence of CD in adolescents with susceptibility genotypes, similar to other autoimmune or allergic disorders, and regional differences in consumer practices of gluten avoidance were reported. Methods: Among 22,277 participants in the National Health and Nutrition Examination Survey 2009-2014, we identified persons with CD by testing CD serology or by both a health care provider diagnosis and adherence to a gluten-free diet. Similarly, PWAG were defined as adherent to a gluten-free diet without a CD diagnosis. Consumer behavior and characteristics of both groups, CD and PWAG were compared with those without these conditions, using survey-weighted generalized logistic regression. Results: Participants with CD considered nutrition very important when grocery shopping and tended to have more constipation and thyroid disease. PWAG tended to spend more money on groceries, purchase organic foods, and check food labels more frequently during grocery shopping. They also reported having more food allergies, asthma, and thyroid disease. Conclusions: Our study confirms that CD and PWAG share comorbidities of autoimmune nature. PWAG had more autoimmune/allergy-related disorders that may be associated with non-celiac gluten sensitivity a self-justifiable reason to be on the diet.
Personalized molecular modeling for pinpointing associations of protein dysfunction and variants associated with hereditary cancer syndromes
Macklin, Sarah , Mohammed, Ahmed , Jackson, Jessica L. , Hines, Stephanie L., Caulfield, Thomas R. , Jackson, Jessica, Caulfield, Thomas R , Atwal, Paldeep S

Mayo Clinic

Molecular Genetics & Genomic Medicine | July 25, 2018 | Volume: 6 | Issue: 5 | Pages: 805-810

10.1002/mgg3.447 | PMID 30043523 Get It

AbstractBackgroundAlthough the process of reclassification of a variant of uncertain significance can be complex, they are commonly detected through molecular testing. It often takes years before enough clinical data are acquired, and it can be costly and time‐consuming to perform functional analysis of a single variant. It is important that other tools are developed to aid in clarifying how a specific genetic variant impacts a protein's function, and ultimately the health of the patient.MethodsTwo more newly characterized, suspected pathogenic variants in NBN and PTEN were analyzed through personalized protein modeling. Comparisons between the wild‐type and altered protein were studied using simulations, genomic exome analysis, and clinic study.ResultsModeling of the new NBN and PTEN protein structures suggested loss of essential domains important for normal enzymatic function for these personalized genomic examples which matched the clinical findings.ConclusionThe defects detected through modeling were consistent with the expected clinical effect. Personalized protein modeling is another tool for determination of correct variant classification, which can become further useful through construction of deposition archive.
A Call to Action for Optimizing the Electronic Health Record in the Parenteral Nutrition Workflow
Vanek, Vincent W., Ayers, Phil , Kraft, Michael D. , Bouche, Jean M., Do, Van T., Durham, Charles W., Guenter, Peggi , Hoggle, Lindsey, Kent, Sue, Lin, Emily T., Molinar, L. Steven , Plogsted, Steven W., Poehls, Jessica M., Turner, Peggy, Way, Charles W. Van , Kraft, Michael , Van Way, Charles , Durham, Charles W.

Mayo Clinic

Nutrition in Clinical Practice | July 25, 2018 | Volume: 33 | Issue: 5 | Pages: No page available

10.1002/ncp.10095 | PMID 30043492 Get It

AbstractParenteral nutrition (PN) is a complex therapeutic modality provided to neonates, children, and adults for various indications. Surveys have shown that current electronic health record (EHR) systems are in need of functionality enhancement for safe and optimal delivery of PN. This is a consensus statement from the American Society for Parenteral and Enteral Nutrition, the Academy of Nutrition and Dietetics, and the American Society of Health‐System Pharmacists outlining some of the key challenges to prescribing, order review/verification, compounding, and administration of PN using EHRs today and is a call to action for clinicians and vendors to optimize their EHRs regarding the PN build and workflow.
Outcomes of critical illness: what is meaningful?
Gajić, Ognjen, Ahmad, Sumera , Wilson, Michael E. , Kaufman, David A. , Gajic, Ognjen

Mayo Clinic

Current Opinion in Critical Care | July 25, 2018 | Volume: 24 | Issue: 5 | Pages: 394-400

10.1097/mcc.0000000000000530 | PMID 30045089 Get It

Purpose of review In this review, we will discuss efforts and challenges in understanding and developing meaningful outcomes of critical care research, quality improvement and policy, which are patient-centered and goal concordant, rather than mortality alone. We shall discuss different aspects of what could constitute outcomes of critical illness as meaningful to the patients and other stakeholders, including families and providers. Recent findings Different outcome pathways after critical illness impact the patients, families and providers in multiple ways. For patients who die, it is important to consider the experience of dying. For the increasing number of survivors of critical illness, challenges of survival have surfaced. The physical, mental and social debility that survivors experience has evolved into the entity called post-ICU syndrome. The importance of prehospital health state trajectory and the need for the outcome of critical care to be aligned with the patients’ goals and preferences have been increasingly recognized. Summary A theoretical framework is outlined to help understand the impact of critical care interventions on outcomes that are meaningful to patients, families and healthcare providers.
Immunoglobulin light chain amyloidosis: 2018 Update on diagnosis, prognosis, and treatment
Gertz, Morie A. , Gertz, Morie A

Mayo Clinic

American Journal of Hematology | July 25, 2018 | Volume: 93 | Issue: 9 | Pages: 1169-1180

10.1002/ajh.25149 | PMID 30040145 Get It

AbstractDisease OverviewImmunoglobulin light chain amyloidosis is a clonal, nonproliferative plasma cell disorder in which fragments of immunoglobulin light or heavy chain are deposited in tissues. Clinical features depend on organs involved but can include restrictive cardiomyopathy, nephrotic syndrome, hepatic dysfunction, peripheral/autonomic neuropathy, and “atypical multiple myeloma.”DiagnosisTissue biopsy stained with Congo red demonstrating amyloid deposits with apple‐green birefringence is required for diagnosis. Invasive organ biopsy is not required because amyloid deposits can be found in bone marrow, salivary gland, or subcutaneous fat aspirate in 85% of patients. Verification that amyloid is composed of immunoglobulin light chains is mandatory. The gold standard is laser capture mass spectroscopy.PrognosisN‐terminal pro‐brain natriuretic peptide (NT‐proBNP), serum troponin T, and difference between involved and uninvolved immunoglobulin free light chain values are used to classify patients into four groups of similar size; median survivals are 94.1, 40.3, 14.0, and 5.8 months.TherapyAll patients with a systemic amyloid syndrome require therapy to prevent deposition of amyloid in other organs and prevent progressive organ failure. Stem cell transplant (SCT) is preferred, but only 20% of patients are eligible. Requirements for safe SCT include systolic blood pressure >90 mm Hg, troponin T < 0.06 ng/mL, age < 70 years, and serum creatinine ≤1.7 mg/dL. Nontransplant candidates can be offered melphalan‐dexamethasone or cyclophosphamide‐bortezomib‐dexamethasone. Daratumumab appears to be highly active in AL amyloidosis. Antibodies designed to dissolve existing amyloid deposits are under study.Future ChallengesDelayed diagnosis remains a major obstacle to initiating effective therapy.Educational ObjectivesUpon completion of this educational activity, participants will be better able to: Master recognition of clinical presentations that should raise suspicion of amyloidosis. Understand simple techniques for confirming the diagnosis and providing material to classify the protein subunit. Recognize that a tissue diagnosis of amyloidosis does not indicate whether the amyloid is systemic or of immunoglobulin light chain origin. Understand the roles of the newly introduced chemotherapeutic and investigational antibody regimens for the therapy of light chain amyloidosis.